申请人:Merck Patent Gesellschaft
公开号:US05238937A1
公开(公告)日:1993-08-24
The invention relates to novel chroman derivatives of the formula I ##STR1## in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8 and R.sup.9 have the meanings given in [Patent claim 1], and which, like their salts, show effects on the cardiovascular system and can be used for the treatment or prophylaxis of cardiac insufficiency, angina pectoris, high blood pressure, incontinence and alopecia.
该发明涉及公式I的新型色苷衍生物,其中R.sup.1、R.sup.2、R.sup.3、R.sup.4、R.sup.5、R.sup.6、R.sup.7、R.sup.8和R.sup.9的含义如[专利权要求1]所示,并且这些衍生物及其盐具有对心血管系统的作用,可用于治疗或预防心力衰竭、心绞痛、高血压、尿失禁和脱发。